Changes for page Methodology
Last modified by manuelmenendez on 2025/03/14 08:31
From version 23.1
edited by manuelmenendez
on 2025/02/15 12:55
on 2025/02/15 12:55
Change comment:
There is no comment for this version
To version 22.1
edited by manuelmenendez
on 2025/02/15 12:55
on 2025/02/15 12:55
Change comment:
There is no comment for this version
Summary
-
Page properties (1 modified, 0 added, 0 removed)
Details
- Page properties
-
- Content
-
... ... @@ -11,7 +11,7 @@ 11 11 |=**Category**|=**Description** 12 12 |**Molecular Biomarkers**|Omics-based markers (genomic, transcriptomic, proteomic, metabolomic, lipidomic) 13 13 |**Neuroimaging Biomarkers**|Structural (MRI, CT), Functional (fMRI, PET), Molecular Imaging (tau, amyloid, α-synuclein) 14 -|**Fluid Biomarkers**|CSF, plasma, blood-based markers for tau, amyloid, α-synuclein, TDP-43, GFAP, NfL , autoantiboides14 +|**Fluid Biomarkers**|CSF, plasma, blood-based markers for tau, amyloid, α-synuclein, TDP-43, GFAP, NfL 15 15 |**Neurophysiological Biomarkers**|EEG, MEG, evoked potentials (ERP), sleep-related markers 16 16 |**Digital Biomarkers**|Gait analysis, cognitive/speech biomarkers, wearables data, EHR-based markers 17 17 |**Clinical Phenotypic Markers**|Standardized clinical scores (MMSE, MoCA, CDR, UPDRS, ALSFRS, UHDRS)